Search - tctmd.com

Displaying 21 - 40 of 47

Sort: Relevancy | Date

Presentation TCT 2022

Case #1: Multivessel Coronary Artery Disease

Presenter: Aakriti Gupta

September 17, 2022

News Daily News

COURAGE and ORBITA Had No Impact on Elective PCI Rates in UK

Michael O'Riordan

September 15, 2022

News Daily News

Stable Chest Pain Guideline Data Standards Developed to Add Uniformity

Yael L. Maxwell

September 02, 2022

News Daily News

Even With Revascularization in ISCHEMIA, Skipping Meds Hurt Health Status

Todd Neale

August 19, 2022

News Daily News

CV Symptoms Deserve More Attention, Quantification: AHA Statement

Yael L. Maxwell

August 18, 2022

News Opinion CV Team Dispatch

August 2022 News Roundup

L.A. McKeown

August 01, 2022

News Daily News

CABG Bests PCI in Patients With Good Physical, Mental Health: SYNTAXES

Michael O'Riordan

July 22, 2022

News Daily News

LVEF Analysis Digs Anew Into Revascularization Benefits in Ischemic CAD

Michael O'Riordan

July 11, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for June 2022

Caitlin E. Cox

July 04, 2022

News Daily News

Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients

L.A. McKeown

June 29, 2022

News

‘Less Is More’ for Patients With AF and Stable CAD: AFIRE Analysis

Todd Neale

June 17, 2022

News Conference News EuroPCR 2022

CCTA Increases Contrast Volume in Patients With Prior CABG: GREECE Trial

Yael L. Maxwell

May 24, 2022

News Conference News EAS 2022

Stepwise or Hammer Down? Experts Debate Best Approach to LDL-Lowering

Michael O'Riordan

May 24, 2022

News Conference News EuroPCR 2022

Long-term Outcomes With PCI and CABG: More Analyses to Stir the Pot

Michael O'Riordan

May 23, 2022

News Daily News

Good News and Bad for High-Intensity Statin Use in ASCVD

Michael O'Riordan

May 05, 2022

News Daily News

Don’t Rule Out CABG for Elderly Patients With Multiple Comorbidities

Michael O'Riordan

April 25, 2022

News Daily News

Revascularization’s Benefits in HFrEF Linked to Gains in LV Function

Caitlin E. Cox

April 15, 2022

News Conference News ACC 2022

Modest Effects, Safety Concerns Plague Vupanorsen in TRANSLATE-TIMI 70

Michael O'Riordan

April 07, 2022

News Conference News ACC 2022

In ANOCA, Diltiazem Fails to Improve Vasomotor Function: EDIT-CMD

Caitlin E. Cox

April 02, 2022

News Daily News

Clopidogrel Superior to ‘Divine’ Aspirin Monotherapy in Secondary Prevention

Michael O'Riordan

March 30, 2022

Advertisement

Case #1: Multivessel Coronary Artery Disease

COURAGE and ORBITA Had No Impact on Elective PCI Rates in UK

Stable Chest Pain Guideline Data Standards Developed to Add Uniformity

Even With Revascularization in ISCHEMIA, Skipping Meds Hurt Health Status

CV Symptoms Deserve More Attention, Quantification: AHA Statement

August 2022 News Roundup

CABG Bests PCI in Patients With Good Physical, Mental Health: SYNTAXES

LVEF Analysis Digs Anew Into Revascularization Benefits in Ischemic CAD

TCTMD’s Top 10 Most Popular Stories for June 2022

Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients

‘Less Is More’ for Patients With AF and Stable CAD: AFIRE Analysis

CCTA Increases Contrast Volume in Patients With Prior CABG: GREECE Trial

Stepwise or Hammer Down? Experts Debate Best Approach to LDL-Lowering

Long-term Outcomes With PCI and CABG: More Analyses to Stir the Pot

Good News and Bad for High-Intensity Statin Use in ASCVD

Don’t Rule Out CABG for Elderly Patients With Multiple Comorbidities

Revascularization’s Benefits in HFrEF Linked to Gains in LV Function

Modest Effects, Safety Concerns Plague Vupanorsen in TRANSLATE-TIMI 70

In ANOCA, Diltiazem Fails to Improve Vasomotor Function: EDIT-CMD

Clopidogrel Superior to ‘Divine’ Aspirin Monotherapy in Secondary Prevention

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content